Tell FDA to Use the CARES Act to Prevent Drug Shortages

The U.S. government and Operation Warp Speed should be commended for their tireless efforts to protect Americans from the COVID-19 pandemic. At the same time, we must also ensure continued treatment access for patients who are managing eye diseases and other complex conditions. Government-mandated COVID-19 vaccine production orders related to Operation Warp Speed have dramatically

Call for Nominations for Jenny Pomeroy Award for Excellence in Vision and Public Health and the Rising Visionary Award

Recipients to be honored at 10th Annual Focus on Eye Health National Summit Prevent Blindness has issued the call for nominations for the “2021 Jenny Pomeroy Award for Excellence in Vision and Public Health,” and the second annual “Rising Visionary Award.” Both the awards will be formally presented at the Tenth Annual Prevent Blindness Focus

FDA Authority to Help Prevent Drug Shortages for Patients with Eye Diseases & Other Conditions

How the FDA Can Help Prevent Drug Shortages Without Disrupting COVID-19 Vaccine Manufacturing The U.S. government and Operation Warp Speed are in the process of producing and distributing COVID-19 vaccines. While this vast private/public program is moving as quickly as possible to bring vaccines to Americans and end the pandemic, the U.S. Food and Drug

Join The Glaucoma Community to Fight the Sneak Thief of Sight

Prevent Blindness provides variety of free resources, educational tools in support of January’s National Glaucoma Awareness Month Today, there are more than an estimated 3.7 million older adults in the United States with glaucoma, according to the report, “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems.” In an effort to help save

Prevent Blindness Opposes Trump Administration’s “Most Favored Nation” Policies

Prevent Blindness sharply opposes the Trump Administration’s finalization of its “Most Favored Nations” (MFN) rule, which will take effect in January 2021. As a patient advocacy organization, Prevent Blindness promotes policies that encourage patient-centered decision-making and consumer choice while mitigating over-utilization and over-consumption without harming accessibility. We believe policies should balance provider behavior with appropriate

Prevent Blindness Declares December as “Give the Gift of Sight Month”

Prevent Blindness, Seeks Public Support to Continue to Help Provide Sight-saving Services Since 1908, Prevent Blindness has worked to provide services and programs to protect vision in the United States. Through the support of the American public, Prevent Blindness has continued its mission to advocate, educate and empower people to make healthy vision a priority.

Regener-Eyes® is Pledging Support to Prevent Blindness this Holiday Season

Regener-Eyes® LLC, a subsidiary of Regenerative Processing Plant Inc., announced that Regener-Eyes®, a first in class biologic eye drop, is giving back this holiday season by launching a campaign to help support the ongoing efforts of Prevent Blindness. Now through Jan. 15, 2021, Regener-Eyes® will donate $1 to Prevent Blindness for each purchase of either

Senate Releases Long-Awaited FY2021 Appropriations Legislation

This week, the U.S. Senate Committee on Appropriations released its long-awaited version of Fiscal Year (FY) 2021 appropriations legislation for programs and agencies within the Departments of Health and Human Services, including the Centers for Disease Control and Prevention (CDC) and National Eye Institute (NEI) at the National Institutes of Health (NIH). Because the process

Diabetes-related Eye Disease Month to Educate on Leading Cause of New Cases of Blindness in Adults

Prevent Blindness Offers Informational Resources, Including Factsheets, Training Modules, and Social Media Graphics to Help Save Sight from Diabetes-related Eye Disease Data from the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report, 2020, shows that 34.2 million Americans have diabetes and 88 million American adults have prediabetes. Alarmingly, more people are developing